THE MCMANUS GROUP

Lobbying for GRAIL, INC. · Biotechnology services

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $50,000.00 income · posted Jul 20, 2026

Lobbying activity 1

Medicare/Medicaid

Medicare issues as they relate to oncology and multi-cancer early detection, including diagnostics and screening.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.